Lataa...
Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
BACKGROUND: Psoriasis is a debilitating autoimmune skin disease that affects 2%–3% of the world’s population. Patients with moderate-to-severe plaque psoriasis suffer from a decreased quality of life as well as comorbidities. Newer biological agents have been shown to be more effective than traditio...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3600940/ https://ncbi.nlm.nih.gov/pubmed/23515267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S42424 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|